- Novartis survey uncovers real-world impact of immune thrombocytopenia
- Benchling closes at $14.5M in Series B round
- 2018 BIO International Convention makes history
- Novotech signs pact with CMUH for clinical services
- AbbVie, Eisai launch auto-injector drug delivery pen
- Yaoshibang completes $65.7M financing round
- Esco Group acquires AT Medical UAB
- J & J Innovation to offer new solutions to fight cancer
- TiGenix announces change in its Board of Directors
- Suven Life Sciences gets patents in China and US
- Ganovo approval marks a milestone for MAH policy in China
- Moxidectin gets USFDA nod to treat River Blindness
- Israeli biotech startups to get new workspace
- JHL Biotech appoints new CFO, raises $106M
-
Pharma | 05 January 2018 | News
AstraZeneca collaborates with Myriad Genetics for cancer therapy
AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its tes...Read more
Digital Health | 05 January 2018 | News
Microsoft partners with Adaptive Biotechnologies
The tech giant Microsoft is partnering with Seattle biotech company Adaptive Biotechnologies on a year-long pr...Read more
-
Japan | 15 June 2018 | News
AbbVie, Eisai launch auto-injector drug delivery pen
AbbVie has partnered with Eisai and its gastrointestinal diseases unit EA Pharma to introduce an auto-injectio...Read more
-
World | 15 June 2018 | News
Benchling closes at $14.5M in Series B round
Life Sciences informatics company Benchling said that it closed a $14.5 million Series B round of venture capi...Read more
-
Singapore | 14 June 2018 | News
Esco Group acquires AT Medical UAB
Esco Group has entered into an agreement to acquire the remaining shares in AT Medical UAB, an Esco Ventures p...Read more
-
Pharma | 04 January 2018 | News
Europe's biggest private biotech company raises $270 million
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to supp...Read more
ROBOTICS AND AI - FACE OF NEW HEALTH
Information technology development in healthcare has been rapidly moving from products to services to solutions. The present decade is one of medical platforms focused on real-time, outcome-based care. The next decade is moving towards medical solutions – using Artificial intelligence (AI), robotics, and virtual and augmented reality – to deliver intelligent solutions for both evidence- and outcome-based health and focusing on collaborative, preventative care. This drastic confluence is leading to AI and robotics defining the face of new health.
